- GSK introduces Haleon to investors🔍
- GSK announces independent Consumer Healthcare company is to ...🔍
- Glaxosmithkline plc🔍
- gsk|announces|intention|to|sell|shares|in|haleon.pdf🔍
- GSK's Haleon will launch with more than £10B in debt🔍
- GSK Capital Markets Day🔍
- Consumer Healthcare Demerger🔍
- GlaxoSmithKline unveils Haleon🔍
GSK introduces Haleon to investors
GSK will announce that the proposed listing of Haleon (the newly independent company to be formed following the demerger of the GSK Consumer Healthcare ...
The name was also announced in advance of GSK hosting a Consumer Healthcare Capital Markets Day for investors and analysts on Monday 28 February ...
Glaxosmithkline plc: GSK introduces Haleon to investors - Cbonds
Issued: 28 February 2022, London UK GSK introduces Haleon to investors · Global leader in consumer health set to be a newly independent company with focused ...
The disposal announced today will be conducted through a placing of ordinary shares in Haleon to institutional investors (the "Offering").
GSK introduces Haleon to investors - Markets data
At an update to investors today, GSK will announce that the proposed listing of Haleon (the newly independent company to be formed following the ...
GSK announces independent Consumer Healthcare company is to ...
The creation of Haleon results from a series of successful investments and strategic changes to GSK's consumer health business over the last ...
GSK's Haleon will launch with more than £10B in debt - Fierce Pharma
GSK's consumer healthcare spinoff will launch on the London stock market on July 18 with a new name, a new CEO and around 10.3 billion pounds of debt.
GSK Capital Markets Day - Haleon
... GSK Capital Markets Day to introduce you to Haleon. The ... A copy of today's agenda should be visible on the investors section of gsk.com.
Consumer Healthcare Demerger - GSK
The Demerger completed on Monday 18 July 2022 and GSK shareholders received one Haleon plc share for each GSK plc share held at 6.00pm UK on Friday 15 July 2022 ...
GlaxoSmithKline unveils Haleon, the new brand name for its ...
Haleon, pronounced “Hay-Lee-On,” will be GSK Consumer Health's new name once it spins off from the group and debuts as a standalone company mid-2022.
GSK announces Consumer Healthcare business will be named ...
The launch of Haleon later this year follows a series of investments by GSK over the last eight years, including the integration of consumer ...
Haleon is the result of the combination of three consumer health businesses, GSK, Novartis and Pfizer, over the last decade.
Today marks a significant moment for GSK, as we formally introduce you to Haleon – a new ... For investors, as a new standalone company, Haleon ...
Capital markets day and demerger archive - Haleon
GSK plc demerged it's world leading consumer healthcare business, Haleon, on 18 July 2022. The Capital Markets Day was hosted virtually on 28 February 2022.
... introduction, and initiatives to ... On 6 July 2022, the shareholders of GSK plc voted to approve all resolutions required to implement the.
... Introduction to the premium listing segment of the Official ... The Haleon Shares to be delivered to Shareholders resident in Canada ...
... investors of the securities described herein (the “Securities”). ... GSK under the terms of the Indenture (the “GSK Guarantee”). With effect from ...
The separation of GSK Consumer Healthcare, to form Haleon, is subject to approval from shareholders and will be by way of a demerger of at least ...
Haleon will Launch with $12B+ Debt as New GSK Gains Momentum
When GSK's consumer health spinoff Haleon launches later this month ... Earlier this month, GSK shareholders supported the spinoff ...
GSK announces intention to sell shares in Haleon - Investegate
GSK today announces that it intends to sell up to 240m ordinary shares in Haleon, equivalent to up to 2.5% of Haleon's issued share capital. The ...